Literature DB >> 12049030

Enhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 Cuban outbreaks.

María G Guzmán1, Gustavo Kourí, Luis Valdés, José Bravo, Susana Vázquez, Scott B Halstead.   

Abstract

OBJECTIVE: To understand the possible effect that length of time has on disease severity with sequential dengue infections.
METHODS: Death and hospitalization rates for dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS) per 10,000 secondary dengue-2 infections were compared in the same age group for two dengue-2 (DEN-2) epidemics in Cuba. The first DEN-2 epidemic affected all of Cuba in 1981; the second one, in 1997, impacted only the city of Santiago de Cuba. The sensitizing infection for DHF/DSS for each of the DEN-2 epidemics was dengue-1 (DEN-1) serotype virus, which was transmitted in 1977-1979, that is, 4 years and 20 years before the two DEN-2 epidemics. Using published seroepidemiological data from the cities of Havana and Santiago de Cuba, we estimated the rates at which persons aged 15-39 years old and those 40 years and older were hospitalized or died of DHF/DSS in Havana and in all of Cuba in 1981 and in just Santiago de Cuba in 1997.
RESULTS: Among adults 15-39 years old the death rate per 10,000 secondary DEN-2 infections was 38.5 times as high in Santiago de Cuba in 1997 as in Havana in 1981. As a further indication of the increased severity coming with a longer period between the initial DEN-1 infection and the secondary DEN-2 infection, the case fatality rate for that same age group was 4.7 times as high in Santiago in 1997 as it was in Havana in 1981.
CONCLUSION: We found a marked increase in severity with the longer of the two intervals (20 years) between an initial DEN-1 infection and a secondary DEN-2 infection. Such a difference may be due to subtle shifts in causative dengue strains or to changes with the passage of time in the circulating population of human dengue antibodies. These observations have important implications for dengue control, pathogenic mechanisms, and vaccine development.

Entities:  

Mesh:

Year:  2002        PMID: 12049030     DOI: 10.1590/s1020-49892002000400003

Source DB:  PubMed          Journal:  Rev Panam Salud Publica        ISSN: 1020-4989


  69 in total

1.  Virological surveillance of dengue in Saint Martin and Saint Barthelemy, French West Indies, using blood samples on filter paper.

Authors:  Séverine Matheus; Jean-Loup Chappert; Sylvie Cassadou; Franck Berger; Bhetty Labeau; Laetitia Bremand; Alain Winicki; Patricia Huc-Anais; Philippe Quenel; Philippe Dussart
Journal:  Am J Trop Med Hyg       Date:  2012-01       Impact factor: 2.345

2.  Factors associated with dengue mortality in Latin America and the Caribbean, 1995-2009: an ecological study.

Authors:  Fredi Alexander Díaz-Quijano; Eliseu Alves Waldman
Journal:  Am J Trop Med Hyg       Date:  2012-02       Impact factor: 2.345

Review 3.  Dengue: a continuing global threat.

Authors:  Maria G Guzman; Scott B Halstead; Harvey Artsob; Philippe Buchy; Jeremy Farrar; Duane J Gubler; Elizabeth Hunsperger; Axel Kroeger; Harold S Margolis; Eric Martínez; Michael B Nathan; Jose Luis Pelegrino; Cameron Simmons; Sutee Yoksan; Rosanna W Peeling
Journal:  Nat Rev Microbiol       Date:  2010-12       Impact factor: 60.633

4.  Spatial Distribution of Epidemiological Cases of Dengue Fever in Suriname, 2001-2012.

Authors:  D Hamer; M Lichtveld
Journal:  West Indian Med J       Date:  2015-05-01       Impact factor: 0.171

Review 5.  Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis.

Authors:  Karen Clyde; Jennifer L Kyle; Eva Harris
Journal:  J Virol       Date:  2006-08-23       Impact factor: 5.103

6.  Dengue: where are we today?

Authors:  Maria Guadalupe Guzman; Susana Vázquez; Gustavo Kouri
Journal:  Malays J Med Sci       Date:  2009-07

7.  Variation in inflammatory/regulatory cytokines in secondary, tertiary, and quaternary challenges with dengue virus.

Authors:  Beatriz Sierra; Ana B Pérez; Mayling Alvarez; Gissel García; Katrin Vogt; Eglys Aguirre; Kathrin Schmolke; Hans-Dieter Volk; María G Guzmán
Journal:  Am J Trop Med Hyg       Date:  2012-07-16       Impact factor: 2.345

8.  Elevated levels of vascular endothelial growth factor in adults with severe dengue infection.

Authors:  Preeti Thakur; Anita Chakravarti; Sunita Aggarwal; Beena Uppal; Preena Bhalla
Journal:  Virusdisease       Date:  2016-02-02

9.  Dengue viral infections.

Authors:  Padmalal Gurugama; Pankaj Garg; Jennifer Perera; Ananda Wijewickrama; Suranjith L Seneviratne
Journal:  Indian J Dermatol       Date:  2010       Impact factor: 1.494

10.  Neutralizing antibodies after infection with dengue 1 virus.

Authors:  Maria G Guzman; Mayling Alvarez; Rosmari Rodriguez-Roche; Lidice Bernardo; Tibaire Montes; Susana Vazquez; Luis Morier; Angel Alvarez; Ernest A Gould; Gustavo Kouri; Scott B Halstead
Journal:  Emerg Infect Dis       Date:  2007-02       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.